CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock - CCLDO STOCK NEWS

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) recently received a favorable review from business.com for its electronic health record (EHR) system, Charts, scoring an impressive 8.9 out of 10.

The review praised Charts for its user-friendly interface, robust reporting and analytics, and high level of customization. CareCloud aims to empower healthcare providers with technology that enhances patient care and operational efficiency. The company offers various innovative solutions to improve medical practice management, including revenue cycle management (RCM).

CareCloud's EHR and technology-enabled services aim to streamline operations and boost financial performance for over 40,000 providers nationwide.

CareCloud (Nasdaq: CCLD, CCLDO, CCLDP) is set to announce its financial results for the first quarter ended March 31, 2023, on May 4, 2023, before the market opens. An investor conference call will follow at 8:30 a.m. Eastern Time, with live access available via webcast. Investors can also utilize an audio-only option by calling 416-764-8658. A replay of the call will be available within an hour after its conclusion.

CareCloud specializes in healthcare technology solutions, offering services like revenue cycle management and electronic health records to improve operational performance and patient care. Over 40,000 providers use CareCloud’s solutions to streamline workflows and reduce administrative costs. For further details on their products, visit www.carecloud.com.

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) will exhibit its healthcare technology solutions at the American Alliance of Orthopaedic Executives Annual Conference from April 20-23, 2023, in Orlando. The company will showcase its customizable revenue cycle solutions designed to enhance interoperability, streamline clinical workflows, and address physician burnout. With the support of AI technologies, CareCloud aims to improve patient outcomes and satisfaction through advanced patient experience management tools and telemedicine capabilities. Key features at the booth will include CareCloud Central, CareCloud Charts, and CareCloud Concierge, focusing on productivity, patient care, and revenue optimization.

CareCloud, a leader in healthcare technology, announced its selection by the Heart & Vascular Institute to implement its chronic care management (CCM) program. This initiative aims to empower patients with chronic conditions through personalized care plans, remote monitoring, and regular healthcare provider check-ins. The partnership, which builds on their existing relationship since 2012, seeks to enhance patient engagement, improve outcomes, and reduce hospitalizations. The CCM program is a part of CareCloud's digital health suite launched in April 2022, which also features remote patient monitoring (RPM). The adoption of these solutions is anticipated to boost the Institute's revenue without increasing staffing costs.

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) announced its participation in the HIMSS Global Health Conference from April 17-21, 2023, in Chicago. The company will showcase technology-enabled revenue cycle solutions tailored for healthcare providers. CareCloud emphasizes the importance of secure health information exchange and invests in advanced technologies to support patient-centered care, reducing in-person visit burdens on physicians.

Additionally, CareCloud's medSR division will exhibit consulting services aimed at optimizing workflows and financial operations for healthcare organizations. Hadi Chaudhry, CEO, and CFO Bill Korn will meet with investors during the conference.